KirkcaldyRD, KingBA, BrooksJT. COVID-19 and postinfection immunity: limited evidence, many remaining questions. JAMA 2020. [Epub ahead of print]; DOI: 10.1001/jama.2020.7869
2.
WolfelR, CormanVM, GuggemosW, et al.Virological assessment of hospitalized patients with COVID-2019. Nature, 2020; 581:465–469.
3.
CaoY, SuB, GuoX, et al.Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells. Cell, 2020; 182:73–84.e16.
4.
US Food and Drug Administration. EUA authorized serology test performance. https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance Accessed May7, 2020.
5.
WeitzJS, BeckettSJ, CoenenAR, et al.Intervention serology and interaction substitution: modeling the role of `shield immunity' in reducing COVID-19 epidemic spread. medRxiv 2020. [Epub ahead of print]; DOI: 10.1101/2020.04.01.20049767
6.
BendavidE, MulaneyB, SoodN, et al. COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv 2020. doi.org/10.1101/2020.04.14.20062463
7.
Centers for Disease Control and Prevention. COVID-19 serology surveillance strategy. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/serology-surveillance/index.html Accessed July14, 2020.